Medicines Control Council approves Tarceva® in South Africa for treatment of non-small cell lung cancer
Abstract
Thousands of South African lung cancer patients could now live longer and with improved quality of life if they receive Tarceva
® (erlonitib), a novel alternative to traditional chemotherapy, recently approved by the Medicines Control Council (MCC).
Downloads
Issue
Section
Press Releases